• Abramovits W, Losornio M 2006 Failure of two TNF-alpha blockers to influence the course of alopecia areata. Skinmed. 5: 177-181.

• Ahmed AM, Barahmani N, Duvic M; National Alopecia Areata Registry 2008 Familial alopecia areata and chronic thrombocytopenia. J. Am. Acad. Dermatol. 58: S75-S77.

• Ahmed I, Nasreen S, Bhatti R 2007 Alopecia areata in children. J. Coll. Physicians Surg. Pak. 17: 587-590.

• Aita VM, Christiano AM, Gilliam TC 1999 Mapping complex traits in diseases of the hair and skin. Exp. Dermatol. 8: 439-452.

• Ajith C, Gupta S, Bhansali A, Radotra BD, Kanwar AJ, Kumar B 2005 Alopecia areata associated with idiopathic primary hypophysitis. Clin. Exp. Dermatol. 30: 250-252. *

• Ajith C, Gupta S, Kanwar AJ 2006 Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome. J. Drugs Dermatol. 5: 262-266.

• Akar A, Orkunoglu E, Sengul A, Ozata M, Gur AR 2002 HLA class II alleles in patients with alopecia areata. Eur. J. Dermatol. 12: 236-239.

• Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR 2004 Lack of association between vitamin D receptor FokI polymorphism and alopecia areata. Eur. J. Dermatol. 14: 156-158.

• Akar A, Orkunoglu FE, Tunca M, Tastan HB, Kurumlu Z 2007 Vitamin D receptor gene polymorphisms are not associated with alopecia areata. Int. J. Dermatol. 46: 927-929. *

• Alarcon-Corredor OM, Alfonso R 2007 Clinical and biochemical alterations in rats treated with high doses of vitamin A. Arch. Latinoam. Nutr. 57: 224-230.

• Alexis AF, Dudda-Subramanya R, Sinha AA 2004 Alopecia areata: autoimmune basis of hair loss. Eur. J. Dermatol. 14: 364-370.

• Alexis AF, Dudda-Subramanya R, Siu K, Sinha AA 2007 Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur. J. Dermatol. 17: 367-374.

• Aliagaoglu C, Pirim I, Atasoy M, Egerci N, Aktas A 2005 Association between alopecia areata and HLA class I and II in Turkey. J. Dermatol. 32: 711-714.

• Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100. *

• Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A 2006 Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Clin. Exp. Dermatol. 31: 746-749. *

• Arck P, Paus R 2006 From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 13: 347-356.

• Asherson RA, Giampaolo D, Strimling M 2008 A case of adult-onset Satoyoshi syndrome with gastric ulceration and eosinophilic enteritis. Nat. Clin. Pract. Rheumatol. Jul 8 [Epub ahead of print].

• Ayala-Garcia I, Hernandez-Segura AM, Castell-Rodriguez A, Alvarez Perez SJ, Tellez BH, Ramirez-Gonzalez MD 2005 Participation of epidermal Langerhans cells in human pathology and their potential as targets for drug development: a review of literature. Proc. West. Pharmacol. Soc. 48: 13-20.

• Baala L, Hadj-Rabia S, Hamel-Teillac D, Hadchouel M, Prost C, Leal SM, Jacquemin E, Sefiani A, De Prost Y, Courtois G, Munnich A, Lyonnet S, Vabres P 2002 Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28. J. Invest. Dermatol. 119: 70-76. *

• Barahamani N, de Andrade M, Slusser J, Zhang Q, Duvic M 2002 Interleukin-1 receptor antagonist allele 2 and familial alopecia areata. J. Invest. Dermatol. 118: 335-337. *

• Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M 2006 Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78. *

• Beardi B, Wanert F, Zoller M, Freyschmidt-Paul P, Bodemer W, Kaup FJ 2007 Alopecia areata in a rhesus monkey (Macaca mulatta). J. Med. Primatol. 36: 124-130.

• Betz RC, Konig K, Flaquer A, Redler S, Eigelshoven S, Kortum AK, Hanneken S, Hillmer A, Tuting T, Lambert J, De Weert J, Kruse R, Lutz G, Blaumeiser B, Nothen MM 2008 The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br. J. Dermatol. 158: 389-391. *

• Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, Kortum AK, Tuting T, Lambert J, De Weert J, Hillmer AM, Schmael C, Wienker TF, Kruse R, Lutz G, Blaumeiser B, Nothen MM 2007 Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J. Invest. Dermatol. 127: 2539-2543. *

• Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP 2006 Development and progression of alopecia in the vitamin D receptor null mouse. J. Cell. Physiol. 207: 340-353. *

• Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM 2006 Familial aggregation of alopecia areata. J. Am. Acad. Dermatol. 54: 627-632.

• Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF; Getaid 2003 Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment. Pharmacol. Ther. 18: 401-408. *

• Botta S, Roveto S, Rimoldi D 2007 Seric 21-hydroxilase antibodies in patients with anti-microsomal fraction antibodies. Autoimmune polyendocrine syndrome. Medicina (B. Aires) 67: 143-146.

• Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G 2006 Vitamin D resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20: 627-645.

• Brandimarte G, Tursi A, Giorgetti GM 2002 Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice? Minerva Gastroenterol. Dietol. 48: 121-130.

• Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM 1986 Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77: 749-757.

• Broniarczyk-Dyla G, Prusinska-Bratos M, Dubla-Berner M, Arkuszewska C, Borowiec M, Kowalski ML, Woszczek G 2002 The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Arch. Immunol. Ther. Exp. (Warsz.) 50: 333-336.

• Brown AP, Dunstan RW, Courtney CL, Criswell KA, Graziano MJ 2008 Cutaneous lesions in the rat following administration of an irreversible inhibitor of erbB receptors, including the epidermal growth factor receptor. Toxicol. Pathol. 36: 410-419.

• Bruckner AL 2004 Incontinentia pigmenti: a window to the role of NF-kappaB function. Semin. Cutan. Med. Surg. 23: 116-124.

• Carlton VE, Pawlikowska L, Bull LN 2004 Molecular basis of intrahepatic cholestasis. Ann. Med. 36: 606-617.

• Chapman RW 2003 The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17.

• Chen HY, Guo JL, Li ZG 2008 Significance of anti-cell membrane-associated DNA (mDNA) antibodies in systemic lupus erythematosus. Clin. Rheumatol. 27: 183-187. *

• Chow S, Rizzo C, Ravitskiy L, Sinha AA 2005 The role of T cells in cutaneous autoimmune disease. Autoimmunity 38: 303-317.

• Clarke JT, Price H, Clarke S, George R, Miller JJ 2007 Acquired kinking of the hair caused by acitretin. J. Drugs Dermatol. 6: 937-938.

• Collin P, Reunala T 2003 Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am. J. Clin. Dermatol. 4: 13-20.

• Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD 2006 Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br. J. Dermatol. 154: 1088-1093. *

• Colombe BW, Lou CD, Price VH 1999 The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J. Investig. Dermatol. Symp. Proc. 4: 216-219. *

• Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD 1995 HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol. 33: 757-764.

• Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS 2007 The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol. Assess. 11: 1-112. *

• Cork MJ, Crane AM, Duff GW 1996 Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. Dermatol. Clin. 14: 671-678.

• Courtois G, Israel A 2000 NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection. Sci. STKE 58: PE1. *

• Dao H Jr, Kazin RA 2007 Gender differences in skin: a review of the literature. Gend. Med. 4: 308-328.

• de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M 1999 Alopecia areata in families: association with the HLA locus. J. Investig. Dermatol. Symp. Proc. 4: 220-223. *

• De Weert J, Temmerman L, Kint A 1984 Alopecia areata: a clinical study. Dermatologica 168: 224-229.

• Demay MB 2006 Mechanism of vitamin D receptor action. Ann. N. Y. Acad. Sci. 1068: 204-213.

• Demay MB, Macdonald PN, Skorija K, Dowd DR, Cianferrotti L, Cox M 2007 Role of the vitamin D receptor in hair follicle biology. J. Steroid Biochem. Mol. Biol. 103: 344-346.

• Deplewski D, Rosenfield RL 2000 Role of hormones in pilosebaceous unit development. Endocr. Rev. 21: 363-392. *

• Dhabhai R, Kalla G, Singhi MK, Ghiya BC, Kachhawa D 2005 Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus. Indian J. Dermatol. Venereol. Leprol. 71: 9-13. *

• Dittmar M, Kahaly GJ 2003 Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab. 88: 2983-2992. *

• Dombrowski NC, Bergfeld WF 2005 Alopecia areata: what to expect from current treatments. Cleve. Clin. J. Med. 72: 758, 760-761, 765-766. *

• Du X, Tabeta K, Mann N, Crozat K, Mudd S, Beutler B 2005 An essential role for Rxr alpha in the development of Th2 responses. Eur. J. Immunol. 35: 3414-3423. *

• Dubinsky MC, Fleshner PP 2003 Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr. Treat. Options Gastroenterol. 6: 183-200.

• Dugoujon JM, Cambon-Thomsen A 1995 Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22: 245-260.

• Dunajska K, Szymczak J 2004 Autoimmune multiglandular syndrome type I--a case study. Pol. Merkuriusz Lek. 17: 625-628.

• Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD 1991 HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch. Dermatol. 127: 64-68.

• Duvic M, Norris D, Christiano A, Hordinsky M, Price V 2003 Alopecia areata registry: an overview. J. Investig. Dermatol. Symp. Proc. 8: 219-221. *

• Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB 2007 Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum. Genet. 121: 451-457. *

• Ellis JA, Stebbing M, Harrap SB 2001 Polymorphism of the androgen receptor gene is associated with male pattern baldness. J. Invest. Dermatol. 116: 452-455. *

• Ellison TI, Eckert RL, Macdonald PN 2007 Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. J. Biol. Chem. 282: 10953-10962. *

• Ellison TI, Smith MK, Gilliam AC, Macdonald PN 2008 Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol. May 29 [Epub ahead of print]. *

• Engelhard A, Bauer RC, Casta A, Djabali K, Christiano AM 2008 Ligand-independent regulation of the hairless promoter by vitamin D receptor. Photochem. Photobiol. 84: 515-521.

• Evans GW 1986 Zinc and its deficiency diseases. Clin. Physiol. Biochem. 4: 94-98.

• Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS 2004 Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South. Med. J. 97: 169-171.

• Feldmeyer L, Huber M, Fellmann F, Beckmann JS, Frenk E, Hohl D 2006 Confirmation of the origin of NISCH syndrome. Hum. Mutat. 27: 408-410.

• Fernandez-Faith E, McDonnell J 2007 Cutaneous sarcoidosis: differential diagnosis. Clin. Dermatol. 25: 276-287.

• Fich A, Eliakim R 1988 Does sulfasalazine induce alopecia? J. Clin. Gastroenterol. 10: 466.

• Finetti F, Pellegrini M, Ulivieri C, Savino MT, Paccagnini E, Ginanneschi C, Lanfrancone L, Pelicci PG, Baldari CT 2008 The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity. Blood 111: 5017-5027. *

• Florizoone K, van der Luer R, van den Ingh T 2007 Symmetrical alopecia, scaling and hepatitis in a rabbit. Vet. Dermatol. 18: 161-164. *

• Freyschmidt-Paul P, Happle R, Hoffman R 2004 Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder. J. Dtsch. Dermatol. Ges. 2: 260-273.

• Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S, Zoller M 2006 Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br. J. Dermatol. 155: 515-521. *

• Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israel A, Courtois G, D'Urso M, Ursini MV 2004 Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum. Mol. Genet. 13: 1763-1773. *

• Galbraith GM, Pandey JP 1995 Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum. Genet. 96: 433-436.

• Geier DA, Geier MR 2005 A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38: 295-301.

• Ghyselinck NB, Chapellier B, Calleja C, Kumar Indra A, Li M, Messaddeq N, Mark M, Metzger D, Chambon P 2002 Genetic dissection of retinoic acid function in epidermis physiology. Ann. Dermatol. Venereol. 129: 793-799.

• Gilhar A, Kalish RS 2006 Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun. Rev. 5: 64-69.

• Gilhar A, Paus R, Kalish RS 2007 Lymphocytes, neuropeptides, and genes involved in alopecia areata. J. Clin. Invest. 117: 2019-2027. *

• Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS 1999 Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J. Investig. Dermatol. Symp. Proc. 4: 207-210. *

• Goh C, Finkel M, Christos P, Sinha A 2006 Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J. Eur. Acad. Dermatol. Venereol. 20: 1055-1060. *

• Goldberg LJ, Sekhri V, Bhawan J 2008 Dermal mucin in alopecia areata - tell tale sign or incidental finding? J. Cutan. Pathol. Jan 14 [Epub ahead of print].

• Gopal KV, Rama Rao GR, Kumar YH, Appa Rao MV, Vasudev P; Srikant 2007 Vitiligo: a part of a systemic autoimmune process. Indian J. Dermatol. Venereol. Leprol. 73: 162-165.

• Grogan PM, Katz JS 2004 Inflammatory myopathies. Curr. Treat. Options Neurol. 6: 155-161.

• Gul U, Gonul M, Cakmak SK, Kilic A, Demiriz M 2006 A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%. Adv. Ther. 23: 787-792.

• Gupta P, Freyschmidt-Paul P, Vitacolonna M, Kiessling S, Hummel S, Hildebrand D, Marhaba R, Zoller M 2006 A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. J. Invest. Dermatol. 126: 1559-1573. *

• Gustafsson J, Alimohammadi M, Ekwall O, Gebre-Medhin G, Halldin-Stenlid M, Hedstrand H, Landgren E, Nilsson T, Rorsman F, Skoldberg F, Winqvist O, Kampe O 2004 APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms. Lakartidningen 101: 2096-2098, 2101-2103.

• Ha SJ, Kim JS, Myung JW, Lee HJ, Kim JW 2003 Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia. J. Dermatol. Sci. 31: 135-141.

• Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J 2002 AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87: 2568-2574. *

• Haussmann J, Sekar A 2006 Chronic urticaria: a cutaneous manifestation of celiac disease. Can. J. Gastroenterol. 20: 291-293.

• Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG 2005 The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol. Biomarkers Prev. 14: 993-996. *

• Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG 2007 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int. J. Cancer 120: 776-780. *

• Hengge UR, Ruzicka T 2004 Topical immunomodulation in dermatology: potential of Toll-like receptor agonists. Dermatol. Surg. 30: 1101-1112.

• Herbst V, Zoller M, Kissling S, Wenzel E, Stutz N, Freyschmidt-Paul P 2006 Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur. J. Dermatol. 16: 537-542.

• Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF 2003 Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment. Pharmacol. Ther. 17: 1459-1464. *

• Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, Flaquer A, Freudenberg-Hua Y, Jamra RA, Metzen C, Heyn U, Schweiger N, Betz RC, Blaumeiser B, Hampe J, Schreiber S, Schulze TG, Hennies HC, Schumacher J, Propping P, et al 2005 Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am. J. Hum. Genet. 77: 140-148. *

• Hiroi A, Ito T, Seo N, Uede K, Yoshimasu T, Ito M, Nakamura K, Ito N, Paus R, Furukawa F 2006 Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia? Br. J. Dermatol. 155: 437-445. *

• Hon KL, Leung AK, Ng PC 2008 Unusual loss of body hair in childhood: trichotillomania or alopecia. Adv. Ther. 25: 380-387.

• Hong SB, Jin SY, Park HJ, Jung JH, Sim WY 2006 Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata. J. Korean Med. Sci. 21: 90-94. *

• Hordinsky M, Ericson M 2004 Autoimmunity: alopecia areata. J. Investig. Dermatol. Symp. Proc. 9: 73-78. *

• Horie Y, Kitaichi N, Takemoto Y, Namba K, Yoshida K, Hirose S, Hasumi Y, Ota M, Inoko H, Mizuki N, Ohno S 2007 Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Mol. Vis. 13: 2334-2338.

• Hu Z, Liu JB, Ma SS, Yang S, Zhang XJ 2006 Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr. Dermatol. 23: 114-116. *

• Ishii T, Suzuki Y, Ando N, Matsuo N, Ogata T 2000 Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 85: 2922-2926. *

• Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, Nickoloff BJ, Takigawa M, Paus R 2008 Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J. Invest. Dermatol. 128: 1196-1206. *

• Ito T, Meyer KC, Ito N, Paus R 2008 Immune privilege and the skin. Curr. Dir. Autoimmun. 10: 27-52.

• Jaber SH, Cowen EW, Haworth LR, Booher SL, Berman DM, Rosenberg SA, Hwang ST 2006 Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent. Arch. Dermatol. 142: 166-172. *

• Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M 1998 Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J. Am. Acad. Dermatol. 38: 418-425.

• Kaelin U, Hassan AS, Braathen LR, Yawalkar N 2006 Treatment of alopecia areata partim universalis with efalizumab. J. Am. Acad. Dermatol. 55: 529-532.

• Kakourou T, Karachristou K, Chrousos G 2007 A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J. Eur. Acad. Dermatol. Venereol. 21: 356-359. *

• Kalish RS 2007 Clues from alopecia areata on the role of neuropeptides in the initiation of autoimmunity. J. Invest. Dermatol. 127: 1289-1291. *

• Kalish RS, Gilhar A 2003 Alopecia areata: autoimmunity--the evidence is compelling. J. Investig. Dermatol. Symp. Proc. 8: 164-167. *

• Kasparian A, Floros A, Gialafos E, Kanakis M, Tassiopoulos S, Kafasi N, Vaiopoulos G 2007 Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 16: 505-508.

• Katavetin P, Katavetin P, Wacharasindhu S, Shotelersuk V 2006 A girl with a novel splice site mutation in VDR supports the role of a ligand-independent VDR function on hair cycling. Horm. Res. 66: 273-276.

• Katsinelos P, Kountouras J, Paroutoglou G, Zavos C 2007 Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links? Dig. Dis. Sci. 52: 1288-1292. *

• Kavak A, Baykal C, Ozarmagan G, Akar U 2000 HLA in alopecia areata. Int. J. Dermatol. 39: 589-592.

• Kemp EH, McDonagh AJ, Wengraf DA, Messenger AG, Gawkrodger DJ, Cork MJ, Tazi-Ahnini R 2006 The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum. Immunol. 67: 535-539.

• Khan N, Maheshwari V, Trivedi I, Kalam A 2001 Immunopathology of skin lesions. Indian J. Dermatol. Venereol. Leprol. 67: 234-237.

• King LE Jr, McElwee KJ, Sundberg JP 2008 Alopecia areata. Curr. Dir. Autoimmun. 10: 280-312.

• Koca R, Armutcu F, Altinyazar C, Gurel A 2005 Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med. Sci. Monit. 11: CR296-CR299. *

• Kuwano Y, Fujimoto M, Watanabe R, Asashima N, Nakashima H, Ohno H, Yano S, Yazawa N, Okochi H, Tamaki K 2007 Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. Arch. Dermatol. Res. 298: 493-498. *

• Kuwano Y, Fujimoto M, Watanabe R, Ishiura N, Nakashima H, Ohno Y, Yano S, Yazawa N, Okochi H, Tamaki K 2007 Serum chemokine profiles in patients with alopecia areata. Br. J. Dermatol. 157: 466-473. *

• La Placa M, Vitone F, Bianchi T, Vincenzi C, Gibellini D, Re MC, Tosti A 2004 Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in alopecia areata patients: a hallmark of autoimmune disease? J. Invest. Dermatol. 123: 407-409. *

• Lappe MA 1993 Silicone-reactive disorder: a new autoimmune disease caused by immunostimulation and superantigens. Med. Hypotheses 41: 348-352.

• Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Rowert J, Audring H, Kary S, Burmester GR, Sterry W, Worm M 2007 Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br. J. Dermatol. 156: 486-491. *

• Letada PR, Sparling JD, Norwood C 2007 Imiquimod in the treatment of alopecia universalis. Cutis 79: 138-140.

• Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, Metzger D 2001 RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 128: 675-688. *

• Lueking A, Huber O, Wirths C, Schulte K, Stieler KM, Blume-Peytavi U, Kowald A, Hensel-Wiegel K, Tauber R, Lehrach H, Meyer HE, Cahill DJ 2005 Profiling of alopecia areata autoantigens based on protein microarray technology. Mol. Cell. Proteomics 4: 1382-1390. *

• Mahajan S, Koranne RV, Sharma SK 2003 Cutaneous manifestation of diabetes melitus. Indian J. Dermatol. Venereol. Leprol. 69: 105-108.

• Malloy PJ, Wang J, Peng L, Nayak S, Sisk JM, Thompson CC, Feldman D 2007 A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch. Biochem. Biophys. 460: 285-292. *

• Malloy PJ, Xu R, Peng L, Clark PA, Feldman D 2002 A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol. Endocrinol. 16: 2538-2546. *

• Malloy PJ, Xu R, Peng L, Peleg S, Al-Ashwal A, Feldman D 2004 Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology 145: 5106-5114. *

• Marhaba R, Freyschmidt-Paul P, Zoller M 2006 In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance. Eur. J. Immunol. 36: 3017-3032. *

• Marhaba R, Vitacolonna M, Hildebrand D, Baniyash M, Freyschmidt-Paul P, Zoller M 2007 The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 179: 5071-5081.

• Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, Londono D, Haynes C, Ott J, Hordinsky M, Nanova K, Norris D, Price V, Duvic M, Christiano AM 2007 Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am. J. Hum. Genet. 80: 316-328. *

• Martinez-Mir A, Zlotogorski A, Ott J, Gordon D, Christiano AM 2003 Genetic linkage studies in alopecia areata. J. Investig. Dermatol. Symp. Proc. 8: 199-203. *

• Martucci S, Biagi F, Di Sabatino A, Corazza GR 2002 Coeliac disease. Dig. Liver Dis. 34 Suppl. 2: S150-S153.

• Matsuura E, Matsuyama W, Sameshima T, Arimura K 2007 Satoyoshi syndrome has antibody against brain and gastrointestinal tissue. Muscle Nerve 36: 400-403.

• McClure SL, Valentine J, Gordon KB 2002 Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf. 25: 913-927.

• McDonagh AJ, Messenger AG 1994 The aetiology and pathogenesis of alopecia areata. J. Dermatol. Sci. 7: S125-S135.

• McDonagh AJ, Tazi-Ahnini R 2002 Epidemiology and genetics of alopecia areata. Clin. Exp. Dermatol. 27: 405-409. *

• McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, Zoller M 2005 Transfer of CD8 cells induces localized hair loss whereas CD4/CD25 cells promote systemic alopecia areata and CD4/CD25 cells blockade disease onset in the C3H/HeJ mouse model. J. Invest. Dermatol. 124: 947-957. *

• McElwee KJ, Yu M, Park SW, Ross EK, Finner A, Shapiro J 2005 What can we learn from animal models of alopecia areata? Dermatology 211: 47-53.

• McMichael AJ 2007 The new biologics in psoriasis: possible treatments for alopecia areata. J. Investig. Dermatol. Symp. Proc. 8: 217-218. *

• Meindl S, Rot A, Hoetzenecker W, Kato S, Cross HS, Elbe-Burger A 2005 Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells. Br. J. Dermatol. 152: 231-241. *

• Meyer T, Ruppert V, Karatolios K, Maisch B 2007 Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J. Electrocardiol. 40: 504-509.

• Mohan MP, Ramesh TC 2003 Multiple autoimmune syndrome. Indian J. Dermatol. Venereol. Leprol. 69: 298-299. *

• Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A 1991 DNA polymorphism of HLA class II genes in alopecia areata. Dis. Markers 9: 35-42.

• Moser KL, Gaffney PM, Grandits ME, Emamian ES, Machado DB, Baechler EC, Rhodus NL, Behrens TW 2004 The use of microarrays to study autoimmunity. J. Investig. Dermatol. Symp. Proc. 9: 18-22. *

• Mulinari-Brenner F, Bergfeld WF 2003 Hair loss: diagnosis and management. Cleve. Clin. J. Med. 70: 705-706, 709-710, 712. *

• Murillas R, Larcher F, Conti CJ, Santos M, Ullrich A, Jorcano JL 1995 Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 14: 5216-5223. *

• Nagai H, Oniki S, Oka M, Horikawa T, Nishigori C 2006 Induction of cellular immunity against hair follicle melanocyte causes alopecia. Arch. Dermatol. Res. 298: 131-134. *

• Nagaoka S, Nakamura M, Senuma A, Sekiguchi A 2005 A clinical trial of low dose methotrexate therapy in patients with rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi 28: 389-397.

• Nakamura M, Jo JI, Tabata Y, Ishikawa O 2008 Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (alopecia areata) in a C3H/HeJ mouse model. Am. J. Pathol. 172: 650-658. *

• Namazi MR 2004 Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders. Int. Immunopharmacol. 4: 349-353.

• Namazi MR 2004 The beneficial and detrimental effects of linoleic acid on autoimmune disorders. Autoimmunity 37: 73-75.

• Nanda A 2008 Autoimmune diseases associated with neurofibromatosis type 1. Pediatr. Dermatol. 25: 392-393.

• Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I 2002 Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr. Dermatol. 19: 486-491. *

• Nasr SH, Markowitz GS, Reddy BS, Maesaka J, Swidler MA, D'Agati VD 2006 Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int. 69: 772-775.

• Neufeld M, Maclaren NK, Blizzard RM 1981 Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60: 355-362.

• Nguyen M, d'Alesio A, Pascussi JM, Kumar R, Griffin MD, Dong X, Guillozo H, Rizk-Rabin M, Sinding C, Bougneres P, Jehan F, Garabedian M 2006 Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 21: 886-894. *

• Nicolaidou P, Papadopoulou A, Matsinos YG, Georgouli H, Fretzayas A, Papadimitriou A, Priftis K, Douros K, Chrousos GP 2006 Vitamin D receptor polymorphisms in hypocalcemic vitamin D-resistant rickets carriers. Horm. Res. 67: 179-183.

• Nicolaidou P, Tsitsika A, Papadimitriou A, Karantana A, Papadopoulou A, Psychou F, Liakopoulou D, Georgouli H, Kakourou T, Chrousos G 2007 Hereditary vitamin D-resistant rickets in Greek children: genotype, phenotype, and long-term response to treatment. J. Pediatr. Endocrinol. Metab. 20: 425-430.

• Nnoruka EN, Obiagboso I, Maduechesi C 2007 Hair loss in children in South-East Nigeria: common and uncommon cases. Int. J. Dermatol. 46 Suppl. 1: 18-22.

• No authors listed 1991 Epidemiological evidence of the association between lichen planus and two immune-related diseases. Alopecia areata and ulcerative colitis. Gruppo Italiano Studi Epidemiologici in Dermatologia. Arch. Dermatol. 127: 688-691.

• Norris DA 2003 How close are we to solving the puzzle? Review of the Alopecia Areata Research Workshop David Norris. J. Investig. Dermatol. Symp. Proc. 8: 222-225. *

• Nothen MM, Cichon S, Vogt IR, Hemmer S, Kruse R, Knapp M, Holler T, Faiyaz ul Haque M, Haque S, Propping P, Ahmad M, Rietschel M 1998 A gene for universal congenital alopecia maps to chromosome 8p21-22. Am. J. Hum. Genet. 62: 386-390. *

• O'Sullivan SS, Mullins GM, Neligan A, McNamara B, Galvin RJ 2007 Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis. Clin. Neurol. Neurosurg. 109: 374-375.

• Odum N, Morling N, Georgsen J, Jakobsen BK, Frentz G, Jensen GF, Fugger L, Svejgaard A 1990 HLA-DP antigens in patients with alopecia areata. Tissue Antigens 35: 114-117.

• Okamoto M, Ogawa Y, Watanabe A, Sugiura K, Shimomura Y, Aoki N, Nagasaka T, Tomita Y, Muro Y 2004 Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J. Autoimmun. 23: 257-266.

• Oremovic L, Lugovic L, Vucic M, Buljan M, Ozanic-Bulic S 2006 Cicatricial alopecia as a manifestation of different dermatoses. Acta Dermatovenerol. Croat. 14: 246-252.

• Otberg N, Finner AM, Shapiro J 2007 Androgenetic alopecia. Endocrinol. Metab. Clin. North Am. 36: 379-398.

• Palkina TN, Sharov AA, Sharov TY, Botchkarev VA 2005 Neurotrophins in autoimmune diseases: possible implications for alopecia areata. J. Investig. Dermatol. Symp. Proc. 10: 282. *

• Paus R, Nickoloff BJ, Ito T 2005 A 'hairy' privilege. Trends Immunol. 26: 32-40. *

• Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR 2006 Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch. Dermatol. 142: 1000-1004. *

• Pelivani N, Hassan AS, Braathen LR, Hunger RE, Yawalkar N 2008 Alopecia areata universalis elicited during treatment with adalimumab. Dermatology 216: 320-323.

• Perini P, Calabrese M, Rinaldi L, Gallo P 2007 The safety profile of cyclophosphamide in multiple sclerosis therapy. Expert Opin. Drug Saf. 6: 183-190.

• Phillips MA, Graves JE, Nunley JR 2005 Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. J. Am. Acad. Dermatol. 53: S252-S255.

• Prahalad S, Shear ES, Thompson SD, Giannini EH, Glass DN 2002 Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 46: 1851-1856. *

• Prasad AS 1983 Zinc deficiency in human subjects. Prog. Clin. Biol. Res. 129: 1-33.

• Prasad AS 1985 Clinical manifestations of zinc deficiency. Annu. Rev. Nutr. 5: 341-363.

• Prasad AS 1983 The role of zinc in gastrointestinal and liver disease. Clin. Gastroenterol. 12: 713-741.

• Prelipcean CC, Mihai C, Gogalniceanu P, Mitrica D, Drug VL, Stanciu C 2007 Extragastric manifestations of Helicobacter pylori infection. Rev. Med. Chir. Soc. Med. Nat. Iasi. 111: 575-583.

• Price VH 2007 Therapy of alopecia areata: on the cusp and in the future. J. Investig. Dermatol. Symp. Proc. 8: 207-211. *

• Price VH, Colombe BW 1996 Heritable factors distinguish two types of alopecia areata. Dermatol. Clin. 14: 679-689.

• Price VH, Hordinsky MK, Olsen EA, Roberts JL, Siegfried EC, Rafal ES, Korman NJ, Altrabulsi B, Leung HM, Garovoy MR, Caro I, Whiting DA 2008 Subcutaneous efalizumab is not effective in the treatment of alopecia areata. J. Am. Acad. Dermatol. 58: 395-402.

• Punnam SR, Pothula VR, Gourineni N, Punnam A, Ranganathan V 2008 Interferon-ribavirin-associated ischemic colitis. J. Clin. Gastroenterol. 42: 323-325.

• Rallis E, Nasiopoulou A, Kouskoukis C, Roussaki-Schulze A, Koumantaki E, Karpouzis A, Arvanitis A 2005 Oral administration of cyclosporin A in patients with severe alopecia areata. Int. J. Tissue React. 27: 107-110.

• Ramanathan M, Abidin MN, Muthukumarappan M 1989 The prevalence of skin manifestations in thyrotoxicosis--a retrospective study. Med. J. Malaysia 44: 324-328.

• Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL 2008 Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J. Rheumatol. 35: 572-579.

• Rashtak S, Pittelkow MR 2008 Skin involvement in systemic autoimmune diseases. Curr. Dir. Autoimmun. 10: 344-358.

• Rath HC 2003 Role of commensal bacteria in chronic experimental colitis: lessons from the HLA-B27 transgenic rat. Pathobiology 70: 131-138.

• Robins DN 2007 Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy. J. Drugs Dermatol. 6: 946-947.

• Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P 2004 Cutaneous manifestations of primary Sjogren's syndrome are underestimated. Clin. Exp. Rheumatol. 22: 632-636.

• Ross EK, Vincenzi C, Tosti A 2006 Videodermoscopy in the evaluation of hair and scalp disorders. J. Am. Acad. Dermatol. 55: 799-806.

• Sakai Y, Demay MB 2000 Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology 141: 2043-2049. *

• Sanli H, Akay BN, Arat M, Kocyigit P, Akan H, Beksac M, Ilhan O 2008 Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology 216: 349-354.

• Schafer N, Blaumeiser B, Becker T, Freudenberg-Hua Y, Hanneken S, Eigelshoven S, Schmael C, Lambert J, De Weert J, Kruse R, Nothen MM, Betz RC 2006 Investigation of the functional variant c.-169T > C of the Fc receptor-like 3 (FCRL3) gene in alopecia areata. Int. J. Immunogenet. 33: 393-395. *

• Scheinfeld N 2007 Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis. J. Dermatolog. Treat. 18: 197-208.

• Scherr B, Tromm A, Voigt E, Muller KM, Griga T 2001 Association of primary sclerosing cholangitis and sarcoidosis. Med. Klin. 96: 550-554.

• Schumann C, Faust M, Gerharz M, Ortmann M, Schubert M, Krone W 2005 Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Exp. Clin. Endocrinol. Diabetes 113: 302-307.

• Sehgal VN, Srivastava G, Dogra S 2008 Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I. Skinmed. 7: 27-30.

• Seibold F, Klein R, Jakob F 1996 Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease. J. Clin. Gastroenterol. 23: 121-124.

• Semrad CE 1999 Zinc and intestinal function. Curr. Gastroenterol. Rep. 1: 398-403.

• Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A 2005 Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol. 5: 11. *

• Sherer Y, Kuechler S, Jose Scali J, Rovensky J, Levy Y, Zandman-Goddard G, Shoenfeld Y 2008 Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. Isr. Med. Assoc. J. 10: 55-57. *

• Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H, Nishihira J, Nishimura M, Shimizu H 2005 Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun. 6: 285-289. *

• Skurkovich B, Skurkovich S 2006 Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases. Ernst Schering Res. Found. Workshop. 56: 1-27.

• Soderbergh A, Rorsman F, Halonen M, Ekwall O, Bjorses P, Kampe O, Husebye ES 2000 Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J. Clin. Endocrinol. Metab. 85: 460-463. *

• Soerensen H, Schneidewind-Mueller JM, Lange D, Kashiwagi N, Franz M, Yokoyama T, Ramlow W 2006 Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus. Rheumatol. Int. 26: 409-415. *

• Sood A, Midha V, Sood N, Bansal M 2006 Long term results of use of azathioprine in patients with ulcerative colitis in India. World J. Gastroenterol. 12: 7332-7336. *

• Stenberg AE, Sylven L, Hedstrand H, Kampe O, Hultcrantz M 2007 Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison's disease in girls and women with Turner syndrome. J. Negat. Results Biomed. 6: 10. *

• Sugiyama T, Oishi Y, Sueishi M, Matsumura R, Tomioka H, Akikusa B 1996 Diffuse proliferative lupus nephritis in a patient with ulcerative colitis. Ryumachi 36: 651-655.

• Sundberg JP, Silva KA, Li R, Cox GA, King LE 2004 Adult-onset alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J. Invest. Dermatol. 123: 294-297. *

• Suzuki S, Shimoda M, Kawamura M, Sato H, Nogawa S, Tanaka K, Suzuki N, Kuwana M 2005 Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Eur. J. Neurol. 12: 566-570.

• Tan RS 1974 Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc. R. Soc. Med. 67: 195-196. *

• Tang L, Sundberg JP, Lui H, Shapiro J 2003 Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. J. Investig. Dermatol. Symp. Proc. 8: 212-216. *

• Tarlow JK, Clay FE, Cork MJ, Blakemore AI, McDonagh AJ, Messenger AG, Duff GW 1994 Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J. Invest. Dermatol. 103: 387-390. *

• Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJ, Messenger AG 2002 Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 60: 489-495. *

• Tazi-Ahnini R, Cork MJ, Wengraf D, Wilson AG, Gawkrodger DJ, Birch MP, Messenger AG, McDonagh AJ 2003 Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum. Genet. 112: 400-403. *

• Tazi-Ahnini R, Cox A, McDonagh AJ, Nicklin MJ, di Giovine FS, Timms JM, Messenger AG, Dimitropoulou P, Duff GW, Cork MJ 2002 Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur. J. Immunogenet. 29: 25-30. *

• Tazi-Ahnini R, McDonagh AJ, Wengraf DA, Lovewell TR, Vasilopoulos Y, Messenger AG, Cork MJ, Gawkrodger DJ 2008 The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br. J. Dermatol. Jul 1 [Epub ahead of print]. *

• Tchernev G 2006 Cutaneous sarcoidosis: the "great imitator": etiopathogenesis, morphology, differential diagnosis, and clinical management. Am. J. Clin. Dermatol. 7: 375-382.

• Thomas H, Risma KA, Graham TB, Brody AS, Deutsch GH, Young LR, Joseph PM 2007 A kindred of children with interstitial lung disease. Chest 132: 221-230. *

• Thompson DM, Robinson TW, Lennard-Jones J 1974 Alopecia areata, vitiligo, scleroderma and ulcerative colitis. Proc. R. Soc. Med. 67: 1010-1012. *

• Tietmann C, Bissada NF 2006 Aggressive periodontitis in a patient with chronic cutaneous lupus erythematosus: a case report. Quintessence Int. 37: 401-408.

• Tosti A, Piraccini BM, Iorizzo M, Voudouris S 2005 The natural history of androgenetic alopecia. J. Cosmet. Dermatol. 4: 41-43.

• Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J. Clin. Oncol. 22: 229-237. *

• Trcka J, Kunz M 2006 Functional genome and proteome analyses of cutaneous autoimmune diseases. Curr. Pharm. Des. 12: 3787-3798.

• Treem WR, Veligati LN, Rotter JI, Targan SR, Hyams JS 1993 Ulcerative colitis and total alopecia in a mother and her son. Gastroenterology 104: 1187-1191.

• Tsai LJ, Hsiao SH, Tsai LM, Lin CY, Tsai JJ, Liou DM, Lan JL 2008 The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. Tissue Antigens 71: 114-126. *

• Ulinski T, Perrin L, Morris M, Houang M, Cabrol S, Grapin C, Chabbert-Buffet N, Bensman A, Deschenes G, Giurgea I 2006 APECED syndrome with renal failure: impact of post transplant immunosuppression on disease activity. J. Clin. Endocrinol. Metab. 91: 192-195. *

• Van Bodegraven AA, Pena AS 2003 Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 201-212.

• Viola F, Barbato M, Formisano M, Premate FM, Lucarelli S, Frediani T, Cardi E 1999 Reappearence of alopecia areata in a coeliac patient during an unintentional challenge with gluten. Minerva Gastroenterol. Dietol. 45: 283-285.

• Waiz M, Saleh AZ, Hayani R, Jubory SO 2006 Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata. J. Cosmet. Laser Ther. 8: 27-30.

• Wali A, Ali G, John P, Lee K, Chishti MS, Leal SM, Ahmad W 2007 Mapping of a gene for alopecia with mental retardation syndrome (APMR3) on chromosome 18q11.2-q12.2. Ann. Hum. Genet. 71: 570-577. *

• Wallaschofski H, Meyer A, Tuschy U, Lohmann T 2003 HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm. Metab. Res. 35: 120-124.

• Wan Y, Saghatelian A, Chong LW, Zhang CL, Cravatt BF, Evans RM 2007 Maternal PPAR-gamma protects nursing neonates by suppressing the production of inflammatory milk. Genes Dev. 21: 1895-1890. *

• Wang J, Yang S, Chen JJ, Zhou SM, He SM, Liang YH, Meng W, Yan XF, Liu JJ, Ye DQ, Zhang XJ 2007 Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch. Dermatol. Res. 298: 485-491. *

• Weisman MH, Furst DE, Park GS, Kremer JM, Smith KM, Wallace DJ, Caldwell JR, Dervieux T 2006 Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum. 54: 607-612. *

• Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M 1994 Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J. Invest. Dermatol. 103: 758-763. *

• Wengraf DA, McDonagh AJ, Lovewell TR, Vasilopoulos Y, Macdonald-Hull SP, Cork MJ, Messenger AG, Tazi-Ahnini R 2008 Genetic analysis of autoimmune regulator haplotypes in alopecia areata. Tissue Antigens 71: 206-212. *

• Willemsen R, Vanderlinden J 2008 Hypnotic approaches for alopecia areata. Int. J. Clin. Exp. Hypn. 56: 318-333.

• Wood GA, Flenniken A, Osborne L, Fleming C, Vukobradovic I, Morikawa L, Xu Q, Porter R, Adamson SL, Rossant J, McKerlie C 2005 Two mouse mutations mapped to chromosome 11 with differing morphologies but similar progressive inflammatory alopecia. Exp. Dermatol. 14: 373-379. *

• Xiao FL, Yang S, Yan KL, Cui Y, Liang YH, Zhou FS, Du WH, Gao M, Sun LD, Fan X, Chen JJ, Wang PG, Zhu YG, Zhou SM, Zhang XJ 2006 Association of HLA class I alleles with aloplecia areata in Chinese Hans. J. Dermatol. Sci. 41: 109-119.

• Xiao FL, Zhou FS, Liu JB, Yan KL, Cui Y, Gao M, Liang YH, Sun LD, Zhou SM, Zhu YG, Zhang XJ, Yang S 2005 Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch. Dermatol. Res. 297: 201-209. *

• Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, Chang S, Crumrine D, Yoshizawa T, Kato S, Bikle DD 2002 Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J. Invest. Dermatol. 118: 11-16. *

• Yagishita N, Yamamoto Y, Yoshizawa T, Sekine K, Uematsu Y, Murayama H, Nagai Y, Krezel W, Chambon P, Matsumoto T, Kato S 2001 Aberrant growth plate development in VDR/RXR gamma double null mutant mice. Endocrinology 142: 5332-5341. *

• Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, Liang YH, Lin GS, Lin D, Hu XL, Fan L, Zhang XJ 2004 The genetic epidemiology of alopecia areata in China. Br. J. Dermatol. 151: 16-23. *

• Yang YC, Cheng YW, Lai CS, Chen W 2007 Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: a community-based clinical survey. J. Eur. Acad. Dermatol. Venereol. 21: 643-649. *

• Zoller M, Gupta P, Marhaba R, Vitacolonna M, Freyschmidt-Paul P 2007 Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases. J. Leukoc. Biol. 82: 57-71. *

• Zoller M, McElwee KJ, Vitacolonna M, Hoffmann R 2004 Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J. Autoimmun. 23: 241-256.

Number of references = 253

www psc-literature.org